SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022352
Filing Date
2020-05-07
Accepted
2020-05-07 07:03:56
Documents
72
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q urgn-10q_20200331.htm   iXBRL 10-Q 1951111
2 EX-31.1 urgn-ex311_9.htm EX-31.1 19223
3 EX-31.2 urgn-ex312_6.htm EX-31.2 19262
4 EX-32.1 urgn-ex321_7.htm EX-32.1 9727
5 EX-32.2 urgn-ex322_8.htm EX-32.2 9745
  Complete submission text file 0001564590-20-022352.txt   6752564

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA urgn-20200331.xsd EX-101.SCH 55624
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20200331_cal.xml EX-101.CAL 44666
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20200331_def.xml EX-101.DEF 133885
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20200331_lab.xml EX-101.LAB 377915
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20200331_pre.xml EX-101.PRE 278829
43 EXTRACTED XBRL INSTANCE DOCUMENT urgn-10q_20200331_htm.xml XML 1154721
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 20854520
SIC: 2834 Pharmaceutical Preparations